KARACHI, PAKISTAN – Lucky Core Industries Limited (LCI) has officially denied all market rumors and media reports suggesting the company is divesting from its pharmaceutical operations. In an official statement released today, the company clarified that its pharmaceutical business continues to operate normally as part of its strategic portfolio, and there are no plans to divest this segment.
Recent speculation in various media outlets had suggested that LCI was considering exiting the pharmaceutical sector to focus on its core businesses. However, the company has categorically stated that these reports are completely unfounded and do not reflect its current strategic direction. The pharmaceutical division remains an integral part of LCI’s diversified business model and continues to contribute significantly to the company’s overall performance.
Company Secretary Muhammad Ahsan Malik addressed the situation, stating, “We want to categorically state that Lucky Core Industries is not engaged in any discussions or processes regarding the divestment of our pharmaceutical operations. These reports are baseless and have caused unnecessary speculation in the market. Our pharmaceutical business continues to operate successfully, and we remain committed to all our business segments as part of our long-term growth strategy.”
The clarification comes amid significant market speculation that had affected trading patterns of the company’s shares. LCI emphasized that its pharmaceutical operations, which include popular brands and manufacturing facilities, continue to perform according to expectations and remain a valuable component of the company’s diversified portfolio. The company reaffirmed its commitment to maintaining transparency with its shareholders and the general public regarding any material developments that could affect its operations or strategic direction.
Lucky Core Industries has requested media outlets and market participants to verify information through official channels before publishing or acting on such reports. The company maintains that its current focus remains on optimizing operations across all business segments and creating sustainable value for its stakeholders.
About Lucky Core Industries:
Lucky Core Industries Limited is one of Pakistan’s leading conglomerates with diversified interests in chemicals, pharmaceuticals, biotechnology, and other sectors. The company has a long-standing reputation for quality and innovation across its business divisions.
